Metropolitan Life Insurance CO Allakos Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.72 - $3.18 $3,873 - $7,161	-2,252 Reduced 61.6%	1,404 $3,000
Q2 2023 Aug 10, 2023	BUY	$3.6 - $5.25 $13,161 - $19,194	3,656 New	3,656 $15,000
Q1 2022 May 12, 2022	SELL	$5.08 - $9.81 $46,588 - $89,967	-9,171 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$8.55 - $111.89 $78,412 - $1.03 Million	9,171 New	9,171 $89,000
Q3 2021 Jun 21, 2023	BUY	$76.53 - $110.43 $701,856 - $1.01 Million	9,171 New	9,171 $970,000
Q3 2021 Mar 30, 2023	SELL	$76.53 - $110.43 $33,979 - $49,030	-444 Reduced 4.62%	9,171 $970,000
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $33,979 - $49,030	-444 Reduced 4.62%	9,171 $971,000
Q2 2021 Jun 21, 2023	BUY	$85.37 - $114.1 $820,832 - $1.1 Million	9,615 New	9,615 $820,000
Q2 2021 Mar 30, 2023	BUY	$85.37 - $114.1 $213,937 - $285,934	2,506 Added 35.25%	9,615 $820,000
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $820,234 - $1.1 Million	9,608 Added 137257.14%	9,615 $821,000
Q1 2021 Jun 26, 2023	BUY	$109.73 - $153.66 $780,070 - $1.09 Million	7,109 New	7,109 $816 Million
Q1 2021 Mar 30, 2023	SELL	$109.73 - $153.66 $33,906 - $47,480	-309 Reduced 4.17%	7,109 $815,000
Q1 2021 May 14, 2021	SELL	$109.73 - $153.66 $813,209 - $1.14 Million	-7,411 Reduced 99.91%	7 $816,000
Q4 2020 Jun 22, 2023	BUY	$79.58 - $152.45 $590,324 - $1.13 Million	7,418 New	7,418 $1.04 Million
Q4 2020 Mar 30, 2023	SELL	$79.58 - $152.45 $5,331 - $10,214	-67 Reduced 0.9%	7,418 $1.04 Million
Q4 2020 Feb 16, 2021	SELL	$79.58 - $152.45 $5,331 - $10,214	-67 Reduced 0.9%	7,418 $1.04 Million
Q3 2020 Jun 26, 2023	BUY	$66.43 - $90.99 $497,228 - $681,060	7,485 New	7,485 $609,000
Q2 2020 Jun 26, 2023	BUY	$44.04 - $80.69 $329,639 - $603,964	7,485 New	7,485 $537,000
Q2 2020 Mar 30, 2023	BUY	$44.04 - $80.69 $70,243 - $128,700	1,595 Added 27.08%	7,485 $537,000
Q2 2020 Aug 14, 2020	BUY	$44.04 - $80.69 $70,243 - $128,700	1,595 Added 27.08%	7,485 $538,000
Q1 2020 Jul 12, 2023	BUY	$44.49 - $93.39 $262,046 - $550,067	5,890 New	5,890 $262,000
Q4 2019 Jul 12, 2023	BUY	$66.49 - $137.73 $391,626 - $811,229	5,890 New	5,890 $561,000
Q4 2019 Mar 30, 2023	SELL	$66.49 - $137.73 $11,901 - $24,653	-179 Reduced 2.95%	5,890 $561,000
Q4 2019 Feb 14, 2020	SELL	$66.49 - $137.73 $11,901 - $24,653	-179 Reduced 2.95%	5,890 $562,000
Q3 2019 Jul 12, 2023	BUY	$31.0 - $89.73 $188,139 - $544,571	6,069 New	6,069 $477,000
Q3 2019 Mar 30, 2023	BUY	$31.0 - $89.73 $35,278 - $102,112	1,138 Added 23.08%	6,069 $477,000
Q3 2019 Nov 14, 2019	BUY	$31.0 - $89.73 $35,278 - $102,112	1,138 Added 23.08%	6,069 $477,000
Q2 2019 Jul 12, 2023	BUY	$36.0 - $44.73 $185,544 - $230,538	5,154 New	5,154 $223,000
Q1 2019 Jul 13, 2023	BUY	$33.79 - $51.99 $166,618 - $256,362	4,931 New	4,931 $199,000
Q1 2019 Mar 30, 2023	BUY	$33.79 - $51.99 $166,618 - $256,362	4,931 New	4,931 $199,000
Q1 2019 May 16, 2019	SELL	$33.79 - $51.99 $243,355 - $374,431	-7,202 Reduced 59.36%	4,931 $199,000
Q1 2019 May 15, 2019	BUY	$33.79 - $51.99 $309,921 - $476,852	9,172 Added 309.76%	12,133 $619,000
Q4 2018 Jul 13, 2023	BUY	$31.59 - $62.65 $93,537 - $185,506	2,961 New	2,961 $154,000
Q4 2018 Feb 14, 2019	BUY	$31.59 - $62.65 $62,674 - $124,297	1,984 Added 203.07%	2,961 $155,000
Q3 2018 Jul 13, 2023	BUY	$31.25 - $47.64 $139,406 - $212,522	4,461 New	4,461 $201 Million
Q3 2018 Nov 14, 2018	BUY	$31.25 - $47.64 $30,531 - $46,544	977 New	977 $44,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

Bvf Inc San Francisco, CA

16.6M
Shares

$17.5 Million
0.34% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$6.52 Million
0.31% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$5.3 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$3.73 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.08M
Shares

$3.26 Million
0.13% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $89.8M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account